Quality of Life for IPF Patients with New Medications

Video

The new Idiopathic Pulmonary Fibrosis medications that were recently approved will help with treatment for patients but are not a cure for the condition.

The new Idiopathic Pulmonary Fibrosis medications that were recently approved will help with treatment for patients but are not a cure for the condition.

Marily Glassberg, MD, from the University of Miami said during the recent meeting of the American College of Chest Physicians that the drugs will help in patient treatment but are not the final cure for the condition.

Related Videos
Heart Failure stock imagery. | Credit: Fotolia
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
Joel Gelfand, MD, MSCE: Phototherapy Utility in Psoriasis
Pediatric Hidradenitis Suppurativa Severity not Linked to Obesity
© 2024 MJH Life Sciences

All rights reserved.